Stock listing

NASDAQ:LOXO Loxo Oncology Inc Stock

Follow Loxo Oncology Inc into a list and get an email when it puts out news.

Last close · NASDAQ:LOXO

$234.66 USD

Close on Feb 15, 2019 · No longer trades

Aug 1, 2014 to last close +1,705% · weekly closes, Aug 1, 2014 – Feb 15, 2019
Lowest – highest close
$10.01 – $234.75 USDSince Aug 1, 2014 · lowest Dec 1, 2014 · highest Feb 5, 2019

Delisted NASDAQ:LOXO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:LOXO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Loxo Oncology Inc on 6ix

Decks
7 decks · latest Jan 8, 2018

Decks

DeckKindSlidesDate
Investor Presentation (January 2018)Investor deck45 slidesJan 8, 2018
Corporate Update (June 2017)Corporate update32 slidesJun 5, 2017
2017 ASCO Annual MeetingConference24 slidesJun 5, 2017
Technical Presentation (December 2016)Technical13 slidesDec 19, 2016
Corporate Update (December 2016)Corporate update42 slidesDec 19, 2016
Technical Presentation (April 2016)Technical32 slidesApr 18, 2016
Technical Presentation (November 2015)Technical19 slidesNov 9, 2015

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dov Goldstein
Other companies: BioAge Labs, Inc. (Chief Financial Officer · Since at least Sep 25, 2024); Coya Therapeutics, Inc. (Director · Since at least Dec 28, 2022); Gain Therapeutics, Inc. (Independent Member · Since at least Mar 17, 2021); NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jun 6, 2018 · Past); Durata Therapeutics Inc (Director · Jul 18, 2012 – Jul 24, 2012 · Past); ADMA Biologics Inc (Director · Feb 13, 2012 – Feb 28, 2020 · Past); Cempra Inc (Director · Feb 2, 2012 – Mar 7, 2017 · Past)
CFO and Treasurer · Jul 31, 2014 – Apr 1, 2015 · Past
Lori Kunkel
Other companies: Enliven Therapeutics, Inc. (Director · Since at least Apr 8, 2024); ORIC Pharmaceuticals, Inc. (Director · Since at least Jun 9, 2020); Nurix Therapeutics, Inc. (Director · Jul 23, 2020 – May 19, 2025 · Past); Tocagen Inc (Director · Jun 21, 2018 – Oct 4, 2019 · Past); Curis, Inc. (Director · Jan 22, 2018 – Jan 31, 2022 · Past)
Director · Nov 2, 2017 – Feb 15, 2019 · Past
Timothy M Mayleben
Other companies: Landos Biopharma Inc (Director · May 13, 2021 – May 23, 2024 · Past); Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Feb 7, 2025 · Past); Esperion Therapeutics, Inc. (President & CEO, Director · Jun 25, 2013 – Jan 28, 2021 · Past); Vericel Corporation (President and CEO, Director · Oct 17, 2008 – Aug 29, 2012 · Past)
Director · Jul 28, 2015 – Feb 15, 2019 · Past
Jennifer Burstein
Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019)
Senior VP of Finance · May 1, 2015 – Feb 15, 2019 · Past
Jennifer A LowChief Medical Officer · Jul 31, 2014 – Dec 19, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Loxo Oncology Inc.